Cited by 124Inflammatory Biomarkers in Disease PrognosisCancer, Stress, Anesthesia, and Immune ResponseSepsis Diagnosis and Treatment

Neutrophil to lymphocyte ratio may be predict of mortality in all conditions

Open access
Balta, S, Demirkol, S, Unlu, M, Arslan, Z, Celik, T·2013·British Journal of Cancer

Abstract

We read with great interest the article ‘A derived neutrophil to lymphocyte (N/L) ratio predicts clinical outcome in stage II and III colon cancer patients’ by Absenger et al (2013) . They aimed to investigate the effect of the preoperative N/L ratio on time to recurrence and overall survival in patients with stage II and III colon cancer. They concluded that the N/L ratio is an independent prognostic marker in our study cohort including patients with stage II and III colon cancer. The ready availability of this parameter at no additional cost may encourage its wider use in clinical practice in the future. Thank to the authors for their contribution.

Integrity signals

Registry

Crossref · 10.1038/bjc.2013.598

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Balta, S., Demirkol, S., Unlu, M., Arslan, Z., & Celik, T.
Venue
British Journal of Cancer
Published
2013-10-01
Volume
109
Issue
12
Pages
3125-3126
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2007566709
Cited by
124
References
10
Citations by year
2026: 7 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 6 · 2018: 7 · 2017: 13 · 2016: 12 · 2015: 11 · 2014: 13 · 2013: 2
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
Keywords
neutrophil-to-lymphocyte ratio, mortality prediction, prognostic factors, colon cancer, stage II and III colon cancer, overall survival, time to recurrence, preoperative inflammation
MeSH terms
Colonic Neoplasms, Female, Humans, Lymphocytes, Male, Neutrophils

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review